Education
About Us
Working with TipRanks
Follow Us
AbbVie (GB:0QCV)
LSE:0QCV
Total Valuation
AbbVie has a market cap or net worth of $403.92B. The enterprise value is $464.70B.
Market Cap$403.92B
Enterprise Value$464.70B
Share Statistics
AbbVie has 1,768,169,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,768,169,100
Owned by Insiders0.07%
Owned by Institutions12.46%
Financial Efficiency
AbbVie’s return on equity (ROE) is -1.29 and return on invested capital (ROIC) is 13.69%.
Return on Equity (ROE)-1.29
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)13.69%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee1.11M
Profits Per Employee76.84K
Employee Count55,000
Asset Turnover0.46
Inventory Turnover2.01
Valuation Ratios
The current PE Ratio of AbbVie is 96.7. AbbVie’s PEG ratio is -116.18.
PE Ratio96.7
PS Ratio6.69
PB Ratio-125.12
Price to Fair Value-125.12
Price to FCF22.97
Price to Operating Cash Flow21.02
PEG Ratio-116.18
Income Statement
In the last 12 months, AbbVie had revenue of 61.16B and earned 4.23B in profits. Earnings per share was 2.38.
Revenue61.16B
Gross Profit51.20B
Operating Income21.21B
Pretax Income6.60B
Net Income4.23B
EBITDA28.29B
Earnings Per Share (EPS)2.38
Cash Flow
In the last 12 months, operating cash flow was 19.03B and capital expenditures -329.00M, giving a free cash flow of 18.70B billion.
Operating Cash Flow19.03B
Free Cash Flow18.70B
Free Cash Flow per Share10.58
Dividends & Yields
AbbVie pays an annual dividend of $1.64, resulting in a dividend yield of 4.77%
Dividend Per Share$1.64
Dividend Yield4.77%
Payout Ratio69.42%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change10.09%
50-Day Moving Average223.13
200-Day Moving Average209.80
Relative Strength Index (RSI)52.39
Average Volume (3m)18.30K
Important Dates
AbbVie upcoming earnings date is Apr 24, 2026, Before Open (Confirmed).
Last Earnings DateFeb 4, 2026
Next Earnings DateApr 24, 2026
Ex-Dividend Date―
Financial Position
AbbVie as a current ratio of 0.67, with Debt / Equity ratio of -2106.24%
Current Ratio0.67
Quick Ratio0.56
Debt to Market Cap0.17
Net Debt to EBITDA2.26
Interest Coverage Ratio8.08
Taxes
In the past 12 months, AbbVie has paid 2.36B in taxes.
Income Tax2.36B
Effective Tax Rate0.36
Enterprise Valuation
AbbVie EV to EBITDA ratio is 16.72, with an EV/FCF ratio of 26.55.
EV to Sales7.73
EV to EBITDA16.72
EV to Free Cash Flow26.55
EV to Operating Cash Flow24.86
Balance Sheet
AbbVie has $5.26B in cash and marketable securities with $68.87B in debt, giving a net cash position of -$63.62B billion.
Cash & Marketable Securities$5.26B
Total Debt$68.87B
Net Cash-$63.62B
Net Cash Per Share-$35.98
Tangible Book Value Per Share-$51.10
Margins
Gross margin is 73.34%, with operating margin of 34.69%, and net profit margin of 6.91%.
Gross Margin73.34%
Operating Margin34.69%
Pretax Margin10.79%
Net Profit Margin6.91%
EBITDA Margin46.26%
EBIT Margin15.08%
Analyst Forecast
The average price target for AbbVie is $253.06, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$253.06
Price Target Upside12.65% Upside
Analyst ConsensusModerate Buy
Analyst Count21
Revenue Growth Forecast―
EPS Growth Forecast―